Next earnings date: 12 Aug 2025
cbdMD, Inc. – AMEX:YCBD
Founder-led company
cbdMD stock price today
$0.62
+0.24
+64.43%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
cbdMD stock price monthly change
-35.17%
month
cbdMD stock price quarterly change
-35.17%
quarter
cbdMD stock price yearly change
-46.90%
year
cbdMD key metrics
Market Cap | 1.68M |
Enterprise value | N/A |
P/E | -0.19 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 0.33 |
Price/Book | 0.40 |
PEG ratio | N/A |
EPS | 37.55 |
Revenue | 22.44M |
EBITDA | 9.20M |
Income | 38.90M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -186.16% |
Oper. margin | -177.72% |
Gross margin | 65.01% |
EBIT margin | -177.72% |
EBITDA margin | 40.99% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freecbdMD stock price history
cbdMD stock forecast
cbdMD financial statements
| Mar 2023 | 6.24M | 60.55M | 970.48% |
|---|---|---|---|
| Jun 2023 | 6.11M | -1.77M | -28.93% |
| Sep 2023 | 5.71M | -15.87M | -277.98% |
| Mar 2024 | 4.37M | -4.01M | -91.65% |
| Jun 2023 | 6.11M | -1.77M | -28.93% |
|---|---|---|---|
| Sep 2023 | 5.71M | -15.87M | -277.98% |
| Mar 2024 | 4.37M | -4.01M | -91.65% |
| Oct 2025 | 5.61M | -88.83K | -1.58% |
Analysts Price target
Financials & Ratios estimates
| 2024-08-14 | -0.62 | -0.15 |
|---|
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2020 | 0.42% |
|---|---|
| 2021 | 2.24% |
| 2022 | 29.75% |
| 2023 | 176.12% |
| 2024 |
| Mar 2023 | 33684122 | 7.89M | 23.45% |
|---|---|---|---|
| Jun 2023 | 32969791 | 7.23M | 21.95% |
| Sep 2023 | 16195283 | 7.16M | 44.24% |
| Mar 2024 | 14550138 | 11.46M | 78.78% |
| Mar 2023 | -1.73M | 1.10M | -1.00M |
|---|---|---|---|
| Jun 2023 | -240.57K | -102.38K | 1.47M |
| Sep 2023 | -263.50K | -120.18K | -665.19K |
| Mar 2024 | -704.06K | 4.62K | 1.3M |
cbdMD alternative data
| Aug 2023 | 90 |
|---|---|
| Sep 2023 | 90 |
| Oct 2023 | 90 |
| Nov 2023 | 90 |
| Dec 2023 | 90 |
| Jan 2024 | 52 |
| Feb 2024 | 52 |
| Mar 2024 | 52 |
| Apr 2024 | 52 |
| May 2024 | 52 |
| Jun 2024 | 52 |
| Jul 2024 | 52 |
cbdMD other data
15.56%
-1.08%
of YCBD is owned by hedge funds
9.17M
-446.31K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 10000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | KENNEDY THOMAS RONAN officer: Interim CEO and CFO | Common Stock | 10,000 | $2.1 | $21,000 | ||
Option | SUMICHRAST MARTIN A. director, officer.. | Restricted Stock Units | 250,000 | N/A | N/A | ||
Option | SUMICHRAST MARTIN A. director, officer.. | Restricted Stock Units | 250,000 | N/A | N/A | ||
Option | SUMICHRAST MARTIN A. director, officer.. | Common Stock | 250,000 | N/A | N/A | ||
Option | SUMICHRAST MARTIN A. director, officer.. | Common Stock | 250,000 | N/A | N/A | ||
Option | KENNEDY THOMAS RONAN officer: CFO | Restricted Stock Unites | 16,667 | N/A | N/A | ||
Option | KENNEDY THOMAS RONAN officer: CFO | Common Stock | 16,667 | N/A | N/A | ||
Purchase | KENNEDY THOMAS RONAN officer: CFO & COO | 8% Series A Cumulative Convertible Preferred Stock | 2,300 | $6 | $13,800 | ||
Purchase | KENNEDY THOMAS RONAN officer: CFO & COO | Common stock | 7,400 | $2.04 | $15,096 | ||
Purchase | WIESEHAN JOHN J III officer: Chief Revenue Officer | 8% Series A Cumulative Convertible Preferred Stock | 2,000 | $6 | $12,000 |
| Quarter | Transcript |
|---|---|
| Q2 2023 15 May 2023 | Q2 2023 Earnings Call Transcript |
| Q4 2022 16 Dec 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 13 Aug 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 17 May 2022 | Q2 2022 Earnings Call Transcript |
-
What's the price of cbdMD stock today?
One share of cbdMD stock can currently be purchased for approximately $0.62.
-
When is cbdMD's next earnings date?
cbdMD, Inc. is estimated to report earnings on Tuesday, 12 Aug 2025.
-
Does cbdMD pay dividends?
No, cbdMD does not pay dividends.
-
How much money does cbdMD make?
cbdMD has a market capitalization of 1.68M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 19.35% to 19.48M US dollars. cbdMD made a loss 3.7M US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.
-
What is cbdMD's stock symbol?
cbdMD, Inc. is traded on the AMEX under the ticker symbol "YCBD".
-
What is cbdMD's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of cbdMD?
Shares of cbdMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are cbdMD's key executives?
cbdMD's management team includes the following people:
- Mr. Martin A. Sumichrast Chairman & Co-Chief Executive Officer(age: 58, pay: $441,000)
- Mr. Raymond Scott Coffman Co-Founder, Pres, Co-Chief Executive Officer & Director(age: 63, pay: $186,920)
-
Is cbdMD founder-led company?
Yes, cbdMD is a company led by its founder Mr. Raymond Scott Coffman.
-
How many employees does cbdMD have?
As Jul 2024, cbdMD employs 52 workers.
-
When cbdMD went public?
cbdMD, Inc. is publicly traded company for more then 7 years since IPO on 17 Nov 2017.
-
What is cbdMD's official website?
The official website for cbdMD is cbdmd.com.
-
Where are cbdMD's headquarters?
cbdMD is headquartered at 8845 Red Oak Boulevard, Charlotte, NC.
-
How can i contact cbdMD?
cbdMD's mailing address is 8845 Red Oak Boulevard, Charlotte, NC and company can be reached via phone at +7 044453060.
cbdMD company profile:
cbdMD, Inc.
cbdmd.comExchange:
AMEX
Full time employees:
52
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
8845 Red Oak Boulevard
Charlotte, NC 28217
Charlotte, NC 28217
CIK: 0001644903
ISIN: US12482W3097
CUSIP: 12482W101
